It is known that the ingestion of glucose alone causes a greater increase in plasma glucose levels than ingestion of the same amount of glucose given with other nutrients. Since physiological plasma concentrations of cholecystokinin (CCK) prolong gastric emptying, it is proposed that after a meal, CCK may modify plasma glucose levels by delaying glucose delivery to the duodenum. To evaluate the effect of CCK on oral glucose tolerance, plasma CCK, insulin, and glucose levels and gastric emptying rates were measured in eight normal males before and after the ingestion of 60 g glucose with the simultaneous infusion of either saline or one of two doses of CCK-8 (12 or 24 pmol/kg per h). Gastric emptying rates were measured by gamma camera scintigraphy of technetium 99m sulfur colloid and plasma CCK levels were measured by a sensitive and specific bioassay.
Introduction
Although food intake in normal humans is episodic rather than constant, plasma glucose levels remain regulated within a narrow range of 70-115 mg/dl (1) . Two major factors that regulate plasma glucose levels are (a) the rate of delivery of glucose and carbohydrates from the stomach to the duodenum, where they can be absorbed and (b) the ability of absorbed glucose to release insulin. Both are regulated by the nature of the ingested nutrients, and by gut hormones and neurotransmitters.
Cholecystokinin (CCK) is an established gut hormone that is released after food ingestion and is known to regulate pancreatic exocrine secretion, gallbladder contraction, and bowel motility (2, 3) . In addition to these actions on gastrointestinal functions, studies both in vivo and in vitro in several species have indicated that CCK stimulates insulin release (4) (5) (6) (7) (8) (9) . We lhave recently developed a sensitive and specific bioassay for measuring plasma CCK levels in humans (10, 1 1) . This assay allows detection of basal CCK levels, and is specific for CCK with no detectable interference from other hormones and neurotransmitters (1 1) . Using this bioassay, we reported that the release of CCK is regulated primarily by the ingestion of protein, amino acids, and fat, and not by glucose (1 1) . Moreover, we have recently shown that infusions of CCK, at physiological concentrations, potentiate amino acid-induced (but not glucose-induced) insulin secretion ( 12) . Therefore, one mechanism whereby CCK prevents hyperglycemia after a meal is the augmentation of insulin release. The intrinsic properties of ingested food, such as volume, osmolality, pH, temperature, and ion and nutrient content affect the rate at which the stomach empties (13) (14) (15) (16) (17) . In addition, earlier studies had suggested that CCK plays a role in regulating gastric emptying (18) (19) (20) (21) . To study the role of CCK on this function, we infused CCK at physiological concentrations into humans and found that CCK had a major part in delaying gastric emptying (21) . Therefore, a second mechanism whereby CCK could prevent postprandial hyperglycemia would be in delaying the delivery of carbohydrate from the stomach to the duodenum. glucose in a mixed meal also containing fat and protein (22, 23) . Since glucose is not a major regulator of CCK secretion, it is possible that the postprandial hyperglycemia seen after the ingestion of carbohydrate alone is due, in part, to the lack of CCK release, which, if present, would have both augmented insulin secretion and delayed gastric emptying. In the present study, we have investigated the role of CCK-induced delayed gastric emptying on glucose tolerance. Normal human volunteers were given 60 g oral glucose in the presence and absence of CCK infusions. In these studies plasma CCK, glucose, and insulin levels and gastric emptying rates were measured. These experiments indicate that after the ingestion of glucose, CCK in physiological concentrations delays gastric emptying, slows the delivery of glucose to the duodenum, and reduces hyperglycemia.
Methods
Experimental subjects. Normal healthy male volunteers between 26 and 44 yr of age were studied the morning after an overnight (12) (13) (14) (15) Ingestion of glucose, intravenous infusions, and measurement of gastric emptying. Eight subjects were administered orally 400 ml of a glucose solution containing 60 g of glucose to which 100 usCi of technetium (99mTc)' sulfur colloid had been added. On three separate days and in random order, the same subjects were studied under the following conditions: (a) ingestion of glucose with the simultaneous intravenous infusion of saline, (b) ingestion of glucose with simultaneous infusion of CCK-8 at a rate of 12 pmol/kg per h, and (c) ingestion of glucose with simultaneous infusion of CCK-8 at a rate of 24 pmol/kg per h. Infusions were started 10 min before the ingestion ofglucose and lasted for 100 min. For these studies, synthetic CCK-8 (Kinevac, Squibb Diagnostics, New Brunswick, NJ) was diluted to appropriate concentrations in a total volume of 20 ml saline. The actual infusion rates ofCCK were determined by measuring the CCK concentration of the infusate taken from the delivery system (I1). This measurement corrects for losses of CCK by adsorption of syringes and intravenous tubing. All infusions were given into an antecubital vein using a Harvard pump (Harvard Apparatus Co., Inc., The Ealing Corp., S. Natick, MA). Blood samples were drawn from the contralateral arm. No adverse effects from the CCK infusion were reported by any subjects.
Determinations of gastric emptying were made by gamma scintigraphy ofthe abdomen (21) . A gamma camera interfaced to a computer (ADAC 3350; Analytical Development Assoc. Corp., San Jose, CA) and fitted with a high resolution, low energy, parallel hole collimator was used for imaging. Subjects remained seated between counts but stood in front of the camera for counts taken every 5 min for the first 30 min of the test, and every 15 min thereafter. Although data were collected in both the anterior and posterior projections, only the anterior views were used in calculating the gastric emptying, since the 1. Abbreviations used in this paper. 99mTc, technetium 99m. geometric means of the anterior and posterior projections were very similar to those of the anterior views alone (24). Data were stored on computer disks for subsequent analysis. Using the computer display, the gastric regions were outlined, excluding the small intestine. For each time point, the total radioactivity in the region of interest was summated. Background counts were subtracted and corrections for radionuclide decay were calculated to yield final values for residual radioactivity remaining in the stomach. Background counts were small with respect to the total counts. Counts in the gastric region were expressed as a percentage of the total counts in the whole field in the first five postcibal minutes. The stomach and whole body radiation doses were calculated to be 11 and 1.7 mrads, respectively, for each study (calculations by Mr. Phillip Purser, Mt. Zion Hospital and Medical Center, San Francisco, CA).
Ingestion ofglucose andfat. Four ofthe subjects studied above were also administered orally 400 ml of a solution containing 60 g glucose and 50 g lipid (primarily long-chain triglycerides, Lipomul; Upjohn Co., Kalamazoo, MI) to which 100 1ACi of 99mTc sulfur colloid had been added. Blood was drawn at various times before and after drinking for measurements of plasma CCK, glucose, and insulin levels. Gastric emptying was measured as described above.
Blood sampling and hormone assays. Blood was drawn into iced, heparinized tubes and immediately centrifuged at 2,500 g. Plasma was divided and either immediately extracted for measurement of CCK (10, 11) , stored at -20'C for determination of insulin levels, or kept fresh on ice for prompt measurement ofglucose levels. Plasma glucose concentrations were measured by the glucose oxidase method (Worthington Statzyme; Cooper Biomedical, Malvern, PA) (25). Plasma insulin concentrations were measured by RIA using a double antibody technique (26) .
Plasma CCK concentrations were measured by a highly specific and sensitive bioassay as previously described (10, 11) . This assay is based on the ability of CCK to stimulate amylase release from isolated rat pancreatic acini. Briefly, plasma was extracted and concentrated by adsorption onto octadecylsilylsilica (C- 18 Sep-Pak; Waters Associates, Millipore Corp., Milford, MA) cartridges. CCK was then eluted with 1 ml of 80% ethanol and 0.2% trifluoroacetic acid and the extracts were dried under nitrogen. Plasma extracts were then incubated with isolated rat pancreatic acini for 30 min at 370C and the amylase released into the incubation medium assayed, using procion yellow-coupled starch as substrate. Amylase release expressed as percent of total amylase content was compared with a dose-response curve for CCK-8. With this method, plasma CCK levels as low as 0.2 pM could be detected. The recoveries of CCK-8 and CCK-33 added to charcoalstripped plasma were 90±5 and 86±12%, respectively (11) . Intraassay and interassay coefficients of variation were 7.4 and 10.4%, respectively.
The extensive studies and controls to validate this assay have been previously published (10, 1 1). In brief, several lines ofevidence verified that the amylase stimulatory properties of plasma extracts on isolated pancreatic acini were indeed due to CCK, as previously demonstrated (10, 1 1 (27) and we have recently confirmed this similarity in our bioassay system (28), CCK-8 can be infused to reproduce the total CCK bioactivity of plasma as we have previously demonstrated in studies of gallbladder contraction (1 1) and gastric emptying (21).
Duodenal perfusion ofglucose. In additional studies, four subjects had nasal-duodenal feeding tubes placed for the direct instillation of glucose into the duodenum. For these studies a 10 Fr Graphprobe enteral feeding tube (Zinetics Medical, Salt Lake City, UT) containing a pH electrode was introduced through the nose and localized beyond the pylorus by monitoring the intraluminal pH. The gastric pH was consistently < 2.0 and a prompt stepup to a pH of > 6.0 was observed in all patients as the tip ofthe catheter passed into the duodenum. The tip of the feeding tube was maintained at 65 cm from the nares in alI studies and the intraluminal pH, confirmed throughout each study, was consistently > 6.0. After baseline sampling of blood, subjects received intravenous infusions of either saline or CCK-8 at 24 pmol/kg per h. 10 min after initiating the infusion, glucose (36 g in 240 ml) was perfused through the duodenal feeding tube at a rate of 160 ml/h for 90 min. Blood was drawn at various times for measurements of plasma CCK, glucose, and insulin levels.
Statistical analysis. All values are expressed as the mean±SEM. Differences in plasma glucose and hormone levels were compared using two-way analysis of variance with repeated measures and posthoc analysis was by the Newman-Keuls test (29) . P values of < 0.05 were considered significant.
Results
Plasma CCK, glucose, and insulin responses tofeeding a mixed liquid meal
The stimulatory effect of food on plasma CCK levels was studied in eight normal male volunteers (Fig. 1) . Each subject was fed 400 ml of a mixed liquid meal containing 60 g of carbohydrate plus protein and fat. Plasma CCK levels were measured for up to 90 min. Fasting levels of CCK averaged 1.0±0.1 pM CCK-8 equivalents and rose promptly to 7.1 ± 1.1 pM within 10 min offeeding. CCK levels declined over the next 20 min to 3.9 pM and remained elevated for the 90-min period of study. After the subjects consumed this carbohydrate-containing meal, they showed no significant increase in plasma glucose levels (96-104 mg/dl). In contrast, plasma insulin levels rose from 10.5±4.6 MU/ml to peak levels of 60.8±11.9 gU/ml within 45 min of feeding.
Plasma CCK, glucose, and insulin responses tofeeding glucose in the absence and presence ofCCK infusions CCK responses. Eight normal volunteers were fed 60 g of glucose in 400 ml of water on three occasions. On one occasion no CCK was infused intravenously and on the other occasions CCK was infused at 24 and 12 pmol/kg per h. Ingestion of 60 g glucose without CCK infusion did not significantly increase plasma CCK levels above basal levels (Fig. 2) . Ingestion of glucose plus infusion of CCK at 24 pmol/kg per h resulted in plasma CCK levels averaging 7.7±1.0 pM, a value similar to peak CCK levels observed after the liquid meal. Ingestion of glucose plus infusion of CCK at the lower dose resulted in CCK levels of 4.0±0.8 pM, a value similar to that seen during the second half of the meal. Fig. 2 , all subjects drank 400-ml solutions containing 60 g glucose at time 0. At the times indicated, plasma was collected for measurement of glucose levels. Each value is the mean±SEM of the eight subjects.
Glucose responses. The ingestion of 60 g of glucose, in the absence ofCCK infusion, increased plasma glucose levels from a basal value of 91±3.9 mg/dl to a peak value of 162±1 1 mg/dl (Fig. 3) . Ingestion of glucose, in the presence of the high dose CCK infusion, resulted in significantly lower peak plasma glucose levels of 129±17 mg/dl. Moreover, the integrated glucose response over the 90-min sampling period was significantly lowered (Table I) . Ingestion of glucose in the presence of the lower dose CCK infusion also resulted in decreased peak plasma glucose levels and a decreased integrated glucose response.
Insulin responses. Ingestion of glucose, without exogenous CCK, increased plasma insulin levels from basal values of 10.7±1.8 LU/ml to peak levels of 58±i11 U/ml (Fig. 4) . Ingestion of glucose with infusion of CCK at 24 pmol/kg per h, however, resulted in lower peak levels of insulin at 24.2±4.2 AU/mI. The integrated insulin response over 90 min in the presence of high dose CCK was less than one-third of the control value (Table I) . Plasma insulin levels after glucose in- Effect oforal lipid and glucose on plasma CCK, glucose, and insulin levels, and gastric emptying
To determine if endogenously released CCK exhibited effects similar to those produced by CCK infusion, 50 g lipid was added to the oral glucose solution (Fig. 6 ). Ingestion ofglucose alone did not affect plasma CCK levels, whereas ingestion of glucose plus lipid increased plasma CCK from basal levels of 0.9±0.1 pM to 3.7±0.9 pM within 10 min of feeding. CCK levels remained elevated for up to 90 min. Coincident with this increase in CCK, the rate of gastric emptying of glucose and lipid was significantly slower than that ofglucose alone. At the end of 90 min, 58.5±4.2% of the glucose plus lipid solution remained in the stomach, whereas after 90 min, only 37.5±7.1% of the glucose-alone solution remained in the stomach (P < 0.05). Concomitant with this lipid-induced delay in gastric emptying, plasma glucose and insulin levels were also lower than those after glucose alone. After ingestion ofglucose plus lipid, peak plasma glucose levels were 144±6.8 mg/dl, whereas with glucose alone, levels were 167±9 mg/dl (P < 0.05). Similarly, peak plasma insulin levels after glucose plus lipid ingestion were 46±6.2 uU/ml, whereas with glucose alone, peak insulin levels were 62.7±7 ,uU/ml (P < 0.05). Lack ofan effect ofCCK infusion on duodenally administered glucose
To determine if CCK lowers postprandial hyperglycemia by delaying gastric emptying, plasma CCK, glucose, and insulin levels were measured in four subjects in whom glucose was perfused directly into the duodenum in the absence or presence of a CCK infusion (Fig. 7) . 36 g of glucose was perfused Figure 6 . Effect of oral lipid and glucose on plasma CCK, glucose, and insulin levels, and gastric emptying. Four subjects were given 50 g Lipomul added to the solution of 60 g glucose in a total volume of 400 ml to which 100 MCi of 99mTc sulfur colloid was added. Blood was drawn at the times indicated for measurements of plasma CCK, glucose, and insulin levels, and gastric emptying.
The amount of radioactivity remaining in the stomach is expressed as the percent of total radioactivity in the stomach at time 0. Symbols represent ingestion of either glucose (o) or glucose plus lipid (-).
Each value is the mean±SEM of four subjects. Time (minutes) Figure 7 . Lack of an effect of CCK infusion on duodenally administered glucose. Four subjects had feeding tubes placed into the duodenum through which 36 g glucose was perfused over 90 min. (27) . Since pure synthetic CCK-8 (but not CCK-33) is readily available in large quantities, in the present and previous studies (11, 12, 21) we have infused CCK-8 to reproduce the plasma CCK levels observed after a meal.
It has long been appreciated that hormones and gut factors participate in insulin and glucose metabolism. This appreciation comes from the observations that (a) oral glucose is a more potent stimulant of insulin secretion (despite causing less hyperglycemia) than the same amount ofglucose administered intravenously (37) and that (b) duodenal extracts stimulate insulin secretion when injected into dogs and other animals (38). Several gut hormones have been studied for their ability to stimulate insulin secretion and have been termed incretins. The most extensively studied potential incretin has been glucose-dependent insulinotropic peptide, which stimulates insulin secretion in the presence of hyperglycemia (39) . In rats and other species, CCK, like glucose-dependent insulinotropic peptide potentiates glucose-stimulated insulin secretion (4-9). In humans, however, we have recently observed that pure synthetic CCK, in physiological concentrations, potentiates amino acid-induced insulin secretion, but does not potentiate glucose-induced insulin secretion (12) .
Although CCK does not potentiate glucose-stimulated insulin release, nevertheless, it may have an important role in regulating glucose metabolism through two interrelated mechanisms. First, it has been well documented that after eating a mixed meal there is a marked rise in insulin levels with little or no change in blood glucose levels (1) . Our present studies with a mixed liquid meal gave very similar results. It is known that after the ingestion of a protein-containing meal, plasma amino acids increase (5). Since amino acids are potent stimuli ofbeta cell insulin release, a major stimulus for insulin release after a mixed meal is the increase in plasma amino acids. Since proteins and amino acids stimulate CCK release (11) and CCK potentiates amino acid-induced insulin secretion (12) , it is likely, therefore, that the CCK released after the ingestion of a mixed meal plays an important role in regulating insulin secretion.
Second, the present study suggests an additional mechanism whereby CCK improves postprandial hyperglycemia. Previously we observed that after the ingestion of 400 ml of water, the water emptied from the stomach with a t/2 of < 20 min, whereas the same volume of a mixed liquid meal emptied with a t12 of > 2 h (21). When water was ingested with concomitant infusions of CCK (to achieve plasma concentrations within the physiological range) the gastric emptying of water was similar to that of the mixed liquid meal. The data thus indicated that CCK was a major regulator ofgastric emptying. In the present study, the gastric emptying of 400 ml of glucose had a t/2 of 68 min, a value intermediate between that ofwater and a mixed liquid meal. The infusion of CCK, at concentrations within the physiological range, delayed the emptying of glucose from the stomach and slowed the delivery ofglucose to the duodenum. As a consequence of this CCK effect, glucose absorption from the intestine was delayed, resulting in smaller increases in plasma glucose levels. Moreover, this diminution of postprandial plasma glucose levels occurred despite decreased insulin release.
Two other independent lines ofevidence indicated that the ability of CCK to reduce postprandial hyperglycemia involved an effect on gastric emptying. First, by bypassing the stomach and administering glucose directly into the duodenum, intravenous CCK had no effect on either plasma glucose or insulin levels. Second, adding lipid to the orally ingested glucose as a means of stimulating endogenous CCK secretion delayed gastric emptying and resulted in glucose and insulin levels lower than those seen with oral glucose alone. Together, these data suggest that the rate of gastric emptying is an important determinant of postprandial hyperglycemia and that CCK is an important regulator of gastric emptying.
The findings that CCK reduces postprandial hyperglycemia by both delaying gastric emptying and potentiating amino acid-induced insulin release extends the physiologic role ofthe integrative actions of this hormone. After a meal, in a highly coordinated fashion, CCK (a) regulates the movement of nutrients through the gastrointestinal tract, (b) contracts the gallbladder and stimulates pancreatic exocrine secretion to facilitate digestion, and (c) to maintain euglycemia, potentiates amino acid-induced insulin secretion and delays gastric emptying. CCK thus has an essential role in regulating the intake, processing, and distribution of essential nutrients.
